These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23976958)

  • 21. Metabotropic glutamate receptor 3 is associated with heroin dependence but not depression or schizophrenia in a Chinese population.
    Jia W; Zhang R; Wu B; Dai ZX; Zhu YS; Li PP; Zhu F
    PLoS One; 2014; 9(1):e87247. PubMed ID: 24498053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis of genetic association in opioid dependence susceptibility.
    Nagaya D; Zahari Z; Saleem M; Yahaya BH; Tan SC; Yusoff NM
    J Clin Pharm Ther; 2018 Feb; 43(1):80-86. PubMed ID: 28656735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors.
    Comings DE; Gade R; Wu S; Chiu C; Dietz G; Muhleman D; Saucier G; Ferry L; Rosenthal RJ; Lesieur HR; Rugle LJ; MacMurray P
    Mol Psychiatry; 1997 Jan; 2(1):44-56. PubMed ID: 9154217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.
    Clarke TK; Weiss AR; Ferarro TN; Kampman KM; Dackis CA; Pettinati HM; O'brien CP; Oslin DW; Lohoff FW; Berrettini WH
    Ann Hum Genet; 2014 Jan; 78(1):33-9. PubMed ID: 24359476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations.
    Jacobs MM; Murray J; Byrd DA; Hurd YL; Morgello S
    J Neurovirol; 2013 Oct; 19(5):495-504. PubMed ID: 24078558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium.
    Polimanti R; Walters RK; Johnson EC; McClintick JN; Adkins AE; Adkins DE; Bacanu SA; Bierut LJ; Bigdeli TB; Brown S; Bucholz KK; Copeland WE; Costello EJ; Degenhardt L; Farrer LA; Foroud TM; Fox L; Goate AM; Grucza R; Hack LM; Hancock DB; Hartz SM; Heath AC; Hewitt JK; Hopfer CJ; Johnson EO; Kendler KS; Kranzler HR; Krauter K; Lai D; Madden PAF; Martin NG; Maes HH; Nelson EC; Peterson RE; Porjesz B; Riley BP; Saccone N; Stallings M; Wall TL; Webb BT; Wetherill L; ; Edenberg HJ; Agrawal A; Gelernter J
    Mol Psychiatry; 2020 Aug; 25(8):1673-1687. PubMed ID: 32099098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No genetic association between dopamine D1 receptor gene and [early onset] schizophrenia.
    Zhang C; Fang Y; Xie B; Cheng W; Du Y; Wang D; Yu S
    Psychiatry Res; 2010 May; 177(3):350-3. PubMed ID: 20382433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial.
    Moran M; Blum K; Ponce JV; Lott L; Gondré-Lewis MC; Badgaiyan S; Brewer R; Downs BW; Fynman P; Weingarten A; Cadet JL; Smith DE; Baron D; Thanos PK; Modestino EJ; Badgaiyan RD; Elman I; Gold MS
    Mol Neurobiol; 2021 Jul; 58(7):3335-3346. PubMed ID: 33683627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia.
    Novak G; LeBlanc M; Zai C; Shaikh S; Renou J; DeLuca V; Bulgin N; Kennedy JL; Le Foll B
    Ann Hum Genet; 2010 Jul; 74(4):291-8. PubMed ID: 20456319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population.
    Yuferov V; Butelman ER; Randesi M; Ott J; Kreek MJ
    Neurosci Lett; 2022 Jan; 768():136364. PubMed ID: 34843875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
    Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
    J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.
    Lai IC; Mo GH; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
    Eur J Clin Pharmacol; 2011 Apr; 67(4):383-388. PubMed ID: 21181138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response.
    de Matos LP; Santana CV; Souza RP
    Psychiatry Res; 2015 Sep; 229(1-2):586-8. PubMed ID: 26213377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of DRD1 and DRD2 Receptors for Response Selection Under Varying Complexity Levels: Implications for Metacontrol Processes.
    Zink N; Bensmann W; Arning L; Colzato LS; Stock AK; Beste C
    Int J Neuropsychopharmacol; 2019 Dec; 22(12):747-753. PubMed ID: 31123756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5' UTR polymorphism of dopamine receptor D1 (DRD1) associated with severity and temperament of alcoholism.
    Kim DJ; Park BL; Yoon S; Lee HK; Joe KH; Cheon YH; Gwon DH; Cho SN; Lee HW; NamGung S; Shin HD
    Biochem Biophys Res Commun; 2007 Jun; 357(4):1135-41. PubMed ID: 17466946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of SNP-SNP interaction among ABCB1, ARRB2, DRD1 and OPRD1 on methadone dosage requirement in Han Chinese patients.
    Luo R; Li X; Qin S; Luo Z; Luo X; Hu P; Liu Z; Feng X; Li X
    Pharmacogenomics; 2017 Dec; 18(18):1659-1670. PubMed ID: 29173032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies.
    Chen D; Liu F; Shang Q; Song X; Miao X; Wang Z
    Am J Med Genet B Neuropsychiatr Genet; 2011 Sep; 156B(6):661-70. PubMed ID: 21714067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Support for association between ADHD and two candidate genes: NET1 and DRD1.
    Bobb AJ; Addington AM; Sidransky E; Gornick MC; Lerch JP; Greenstein DK; Clasen LS; Sharp WS; Inoff-Germain G; Wavrant-De Vrièze F; Arcos-Burgos M; Straub RE; Hardy JA; Castellanos FX; Rapoport JL
    Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):67-72. PubMed ID: 15717291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population.
    Zhang D; Shao C; Shao M; Yan P; Wang Y; Liu Y; Liu W; Lin T; Xie Y; Zhao Y; Lu D; Li Y; Jin L
    Biol Psychiatry; 2007 Jun; 61(11):1244-51. PubMed ID: 17157823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction.
    Gerra G; Leonardi C; Cortese E; D'Amore A; Lucchini A; Strepparola G; Serio G; Farina G; Magnelli F; Zaimovic A; Mancini A; Turci M; Manfredini M; Donnini C
    Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):771-5. PubMed ID: 17373729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.